---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-229630"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2023-09-06T23:59:59+00:00"
generated_at: "2026-06-10T23:35:22.966775+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Carmell announces CEO change, board restructuring, and post-merger savings focus on aesthetics

## Summary
- CEO Randy Hubbell resigns effective Aug 31, 2023; Rajiv Shukla (Exec Chair) appointed Chairman & CEO.
- Four directors and four other execs depart as part of Axolotl Biologix integration; no disagreement cited.
- $8M milestone payment to Axolotl rescheduled to Aug 31, 2024; projected annual savings of ~$3M from terminations.
- Focus narrowed to aesthetics programs (skin rejuvenation, dental bone healing) with shorter path to commercialization.

## SEC filing metadata
- accession: 0001193125-23-229630
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2023-09-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/d512811d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-229630
- JSON: https://secwatch.observer/filing/0001193125-23-229630.json
- Plain text: https://secwatch.observer/filing/0001193125-23-229630.txt

## Key facts
- Executive change
  William Newlin resigned as Director at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  James Hart resigned as Chief Medical Officer at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  Donna Godward resigned as Chief Quality Officer at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Chief Quality Officer
  source text: As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  Janet Vargo resigned as Vice President Clinical Services at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Vice President Clinical Services
  source text: As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  Randolph W. Hubbell resigned as Chief Executive Officer and President at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Chief Executive Officer and President
  source text: As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  Steve Bariahtaris resigned as Director at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  Rajiv Shukla was appointed as Chief Executive Officer at Longevity Health Holdings, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: As of the Effective Date, Rajiv Shukla, the Company’s current Executive Chairman, has been appointed as the Chief Executive Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm
- Executive change
  Jaime Garza resigned as Director at Longevity Health Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.